Answers are grounded in this paper and cite their sources.
The use of two different LC–MS techniques, using moving-belt and continuous-flow FAB, has provided complementary means of determining the presence of a diastereomeric impurity within a protected tripeptide pharmaceutical precursor.
No takes yet. Share an insight, caveat, or question.
Ramsey et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: